Skip to content

Drug interactions

Dapsone + Elvitegravir / cobicistat / emtricitabine / tenofovir df

Severity: Moderate

Dapsone and Elvitegravir / cobicistat / emtricitabine / tenofovir df: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dapsone is metabolized partly by CYP3A4 and CYP2C9, and cobicistat is a strong CYP3A4 inhibitor that may raise dapsone exposure. Dapsone toxicity includes dose-related hemolysis and methemoglobinemia. There is no labeled contraindication, and the dapsone-related effects are manageable with monitoring.

What this interaction means in plain words

Dapsone and Elvitegravir / cobicistat / emtricitabine / tenofovir df can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Cobicistat inhibits CYP3A4, reducing dapsone clearance, while elvitegravir's CYP2C9 induction may partially offset this.

What to do

Monitor hemoglobin, methemoglobin and symptoms of hemolysis, and consider a lower dapsone dose if toxicity develops. Check G6PD status before use.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapsone and Elvitegravir / cobicistat / emtricitabine / tenofovir df, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dapsone with Elvitegravir / cobicistat / emtricitabine / tenofovir df?

MediHelp rates the interaction as moderate. Dapsone and Elvitegravir / cobicistat / emtricitabine / tenofovir df can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dapsone is metabolized partly by CYP3A4 and CYP2C9, and cobicistat is a strong CYP3A4 inhibitor that may raise dapsone exposure. Dapsone toxicity includes dose-related hemolysis and methemoglobinemia. There is no labeled contraindication, and the dapsone-related effects are manageable with monitoring.

How serious is the interaction between Dapsone and Elvitegravir / cobicistat / emtricitabine / tenofovir df?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor hemoglobin, methemoglobin and symptoms of hemolysis, and consider a lower dapsone dose if toxicity develops. Check G6PD status before use.

What other medicines interact with Dapsone?

MediHelp also lists interactions of Dapsone with, for example, Bcg vaccine live, Primaquine, Apalutamide. The full list is on the Dapsone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in